The progesterone antagonist onapristone retards the advanced endometrial transformation after gonadotropin stimulation in rabbits.
Ovarian stimulation with gonadotropins (GN) during human in vitro fertilization and embryo transfer (IVF/ET) therapy alters the ovarian steroid output, especially that of progesterone. As a consequence, endometrial transformation is advanced, and embryo implantation is hampered. This study used the rabbit model to determine if the application of the progesterone antagonist (PA) onapristone (ONA) could retard endometrial development after GN-stimulation. Rabbits were GN-stimulated twice daily with 5 IU FSH and 5 IU LH on 3 consecutive days with a) hMG (n = 10) or b) with a mixture of recombinant FSH and LH (n = 10). The animals were then mated, and hCG was injected i.v. to ensure ovulation. This day is designated as day 0 post coitum (d 0 p.c.). On day 2 p.c., five animals of each group were treated with 20 mg ONA/kg body weight and five with vehicle for control. On d 5 p.c. endometrial transformation was analyzed by morphology, uteroglobin (Ugl)-mRNA expression, and proliferation. Embryos were flushed from the uteri. Their number and morphology was evaluated. The endometrium of GN-stimulated control animals demonstrated very long endometrial glands and narrow stromal septa. Ugl-mRNA expression was restricted to the cells at the bottom of the gland. 17.0 +/- 4.6% (mean +/- SD) of glandular cells and 6.0 +/- 5.3% of luminal epithelial cells proliferated. In ONA-treated animals, endometrial glands were significantly shorter, and the pattern of arborization was less pronounced. Endometrial gland cells and luminal epithelial cells expressed Ugl-mRNA. Furthermore, glandular and luminal cells proliferated with high intensity (38.6 +/- 6.8% and 36.4 +/- 9.3%, respectively). These results indicate that the status of endometrial differentiation was retarded after ONA-treatment. Nevertheless, the embryos of these ONA-treated animals were well developed. In conclusion, after GN-stimulation, ONA treatment retarded the advanced endometrial transformation in rabbits. Therefore, postovulatory administration of a PA might be a possible strategy to modulate the advanced endometrial development in IVF-cycles.
Krusche
C A
CA
Department of Anatomy and Reproductive Biology, School of Medicine, RWTH University of Aachen, Wendlingweg 2, D-52057, Aachen, Germany. ckrusche@post.klinikum.rwth-aachen.de
Herrler
A
A
Classen-Linke
I
I
Beier
H M
HM
D000818:Animals; D001755:Blastocyst / Q000166:cytology / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D004717:Endometrium / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D005300:Fertility Agents, Female / Q000494:pharmacology; D006062:Gonadotropins / Q000378:metabolism* / Q000494:pharmacology; D006067:Gonanes / Q000494:pharmacology*; D006727:Hormone Antagonists / Q000494:pharmacology; D023421:Models, Animal; D006080:Ovarian Follicle / Q000166:cytology / Q000187:drug effects; D011247:Pregnancy; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D011817:Rabbits
D005300:Fertility Agents, Female; D006062:Gonadotropins; D006067:Gonanes; D006727:Hormone Antagonists; D012333:RNA, Messenger; C053238:onapristone